(EGFR) [24, 28] . Although growing evidence suggests that LL-37 acts in a receptor-dependent fashion, the exact mechanisms of how it exerts these nonantimicrobial functions are yet to be determined.
FIGURE 1.
The role of HSPGs in mediating immunomodulatory effects of cathelicidins. Following an infectious stimulus, leukocytes and various types of tissue cells produce and release heparin-binding molecules, such as chemokines, growth factors, heparin-binding proteins, and antimicrobial peptides, such as cathelicidins, that bind with high affinity to host and bacterial binding sites, and associate with their diverse heparan sulfate-binding domains on matrix and cell surface proteoglycans. Ligand affinity and concentration determine competitive displacement of heparan sulfate-bound mediators. Activation or inhibition of proteases and heparanases alter constitutive shedding of HSPGs. Binding of cathelicidins to HSPG may alter focal adhesion kinase signaling of syndecan-4 directly; affect coreceptor function of syndecans and glypicans, e.g., by activation of metalloproteinase and syndecan ectodomain shedding or by modification of enzymatic degradation of heparan sulfates by heparanase; and transactivate surface receptors of inflammatory cells, including the formyl peptide receptor, formyl peptide receptor like-1, purinergic receptor, epidermal growth factor receptor, or chemokine receptors. Binding of cathelicidins to heparan sulfate and shedding of HSPGs from cell surfaces at the same time affects microbial virulence and antimicrobial effects of the peptides.
PR-39, the proline-rich antimicrobial peptide of 39 amino acids (SwissProt ID: P80054) is also involved in several cellular processes, such as chemoattraction, angiogenesis, and inflammation [29, 30, 31, 32] . Whether PR-39 utilizes different mechanisms than LL-37 in activating these functions is unknown. Antimicrobial mechanisms of action of PR-39 differ from other cathelicidin peptides. It crosses membranes rapidly and exerts its activity inside microbial cells by blocking bacterial DNA and protein synthesis [2, 33] . The mature peptide is also capable of rapidly crossing eukaryotic cell membranes to bind to SH3 domains of the cytosolic component of the NADPH complex protein p47phox and the signaling adapter protein p130cas [34] . PR-39 is chemoattractive for neutrophils in a calciumdependent and pertussis toxin-inhibitable reaction and contributes to wound healing by stimulating the expression of syndecans, cell surface HSPGs [29] . Removal of HSPGs from the surface of neutrophils abrogates their migratory response to PR-39, but not to fMLP [30] , suggesting that cell surface receptors are involved in PR-39 functions. Evidence also indicates that PR-39 stimulates angiogenesis by inhibiting the ubiquitin proteasome-dependent degradation of hypoxia-inducible factor 1-alpha protein; this selective inhibitory effect of the peptide in the proteasome leads to an anti-inflammatory activity by blocking the degradation of the NF-kB inhibitor IkBa [35] . PR-39 attenuates the apoptotic response of HeLa cells as well as other cell types [36, 37, 38] . These multiple biological activities of PR-39 have been used to prevent postischemic microvascular dysfunction, partly through stabilization of hypoxia-inducible factor 1-alpha [39] . PR-39 has also been identified in human skin-wound fluid and has been shown to increase levels of the cell surface HSPGs syndecan-1 and -4 in NIH 3T3 fibroblasts [40] . PR-39-mediated alterations of cell adhesion and motility are related, in part, to the increased expression of cell surface syndecan-4, a finding that supports the notion that factors that control syndecan-4 expression may play an important role in regulating adhesion-related cell processes [41] . Increased expression of syndecan-1 in hepatocellular carcinoma cells by PR-39 was associated with suppression of motile activity and alteration of actin structure in addition to the suppression of the carcinoma cells' invasive activity [42] . In PR-39-induced migration of neutrophils, modification of HSPGs with sodium chlorate inhibited migration, whereas chemotaxis toward the chemoattractant fMLP was not affected, and removal of heparan sulfates or chondroitin sulfates from the surface of neutrophils by heparinase or chondroitinase inhibited migration toward PR-39, indicating participation of HSPGs of neutrophils -likely syndecans, as both heparinase and chondroitinase were abrogating -in cathelicidin peptide-mediated regulation of the antimicrobial host defense [30] . These observations tightly link HSPGs and PR-39 in cathelicidin-induced immunomodulatory functions.
The polysaccharide heparan sulfate is ubiquitously expressed as a proteoglycan in extracellular matrices and on cell surfaces that function as receptors/coreceptors of extracellular ligands [43] , including many microbes [44] . Among the multiple roles of heparan sulfate in inflammatory responses, it participates in almost every stage of leukocyte transmigration through the blood vessel wall. Heparan sulfate is involved in the initial adhesion of leukocytes to the inflamed endothelium, the subsequent chemokinemediated transmigration through the vessel wall and the establishment of inflammatory reactions. Because of their great structural diversity, a wide range of proteins, such as chemokines, growth factors, and antimicrobial peptides, can bind to the hot spots of heparan sulfate chains, with many proteins binding to unique saccharide sequences. It presents CXC-chemokine ligand 8 (CXCL8) produced by tissue-resident macrophages, to chemokine receptors on leukocytes [43] . All chemokines seem to have the ability to interact with heparan sulfate on the surface of cells and in the extracellular matrix [45] . Human antimicrobial peptides, including LL-37, bind to HSPGs and, vice versa, structural motifs associated with heparin affinity (cationicity, amphipaticity, and consensus regions) confer antimicrobial properties to a given peptide [46] . When liberated from HSPGs by endoglucosidases, these heparin-binding polypeptide mediators are made available for tissue remodeling and angiogenesis, with heparan sulfate on the surface of target cells also being important for signaling through growth factor receptors [43] .
The precise mechanisms, how cathelicidins may interfere with regulatory pathways, are unknown. Leukocyte and vascular HSPGs [43, 47, 48] may change the chemical structure of the heparan sulfate chains they express in response to cathelicidins and thereby alter the inflammatory response with changes in chemokine and growth factor binding known to be important for leukocyte function, angiogenesis, and tissue remodeling, but little is known about this possibility. Furthermore, regulation of heparin sulfate function can occur by changing the accessibility of the polysaccharide at sites of inflammation by proteasemediated shedding of HSPG ectodomains from cell surfaces [49, 50, 51] . Shedding of HSPGs can be regulated by growth factors and chemokines [52, 53] . Interestingly, LL-37 induced keratinocyte migration via metalloproteinase-induced release of heparin-binding EGF from the cell surface that mediates transactivation of EGFR, which stimulates this migration [28] . Such data indicate that HSPG ectodomain shedding may also be regulated by cathelicidins, but further studies are needed. Last but not least, antimicrobial peptides could interact with heparan sulfate and mask ligand binding sites as do heparin sulfate-binding proteins, including antithrombin [54] , platelet factor 4, and histidine-rich glycoprotein [55] , but histidine-rich glycoprotein is also an inhibitor of heparanase activity [56] .
Shed HSPGs, such as syndecan-1 ectodomains, may interfere with host defenses by interacting with different agents of the innate defense system. Purified syndecan-1 ectodomains, through their heparan sulfate chains, bind tightly to peptides of the cathelicidin family, such as PR-39, and inhibit their antibacterial activities [57] . Similar observations have been reported on shed dermatan sulfate-inactivating defensins [58] . Shed ectodomains also bind to neutrophil elastase and cathepsin G [59] ; elastase, at least, has been shown to be important in defending the host against Gram-negative bacterial sepsis [60] . Finally, soluble heparan sulfate can inhibit the activity of several cytokines involved in phagocyte recruitment [61] , implying that heparan sulfate chains of shed ectodomains may act similarly. Such inhibition of soluble, innate host defense factors may be one of the virulence factors of microbes [62] , which activation of an effective innate host response to microbial injury normally would have to successfully counteract.
In summary, there is now ample evidence that the HSPGs participate in many aspects of inflammation. Following an infectious stimulus, leukocytes and various types of tissue cells produce and release heparinbinding molecules, such as chemokines, growth factors, heparin-binding proteins, and antimicrobial peptides, including cathelicidins that bind with high affinity to host or bacterial binding sites and associate with diverse heparan sulfate-binding domains of proteoglycans. Ligand affinity and concentration determine competitive displacement of heparan sulfate-bound mediators. Activation or inhibition of proteases and heparanases alter constitutive shedding of HSPGs. Binding of cathelicidins to HSPG may alter directly focal adhesion kinase signaling of syndecan-4; affect coreceptor function of syndecans and glypicans, e.g., by activation of metalloproteinase and shedding of syndecan ectodomains or by modification of enzymatic degradation of heparan sulfates by heparanase; and transactivate surface receptors of inflammatory cells, including formyl peptide receptor, FPRL1, purinergic receptor, EGFR, and chemokine receptors. At the same time, binding of cathelicidins to heparan sulfate and shedding of HSPGs from cell surfaces affects microbial virulence and the antimicrobial potential of the peptides Nevertheless, much still remains to be understood. For example, there are indications that cathelicidins induce liberation of heparin-binding EGF with subsequent transactivation of EGFR by activation of metalloproteinase [28] , however, the role of cathelicidins in production and shedding of HSPGs by leukocytes, endothelial cells, and other types of cells is unknown. Presence of heparan sulfate-bound cathelicidins in the basement membrane and the effect of cathelicidins on production and release of heparanase used to solubilize HSPGs are unexplored. Furthermore, limited studies indicate that antimicrobial peptides specifically disrupt heparin sulfate-protein interactions. Regulation and molecular mechanisms of such interactions need to be studied in more detail to better understand how cathelicidins may be developed clinically as new anti-inflammatory agents. In conclusion, analysis of the participation of HSPGs in immunomodulatory effects of antimicrobial peptides has reached an interesting stage with various new directions of research now possible. Muinck, E.D., Nagy, N., Tirziu, D., Murakami, M., Gurusamy, N., Goswami, S.K., Ghatpande, S., Engelman, R.M.,
